{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:36:46Z","timestamp":1790624206087,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001202","name":"Gastroenterological Society of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001202","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ebiom.2023.104879","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T09:01:34Z","timestamp":1701421294000},"page":"104879","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Local fistula injection of allogeneic human amnion epithelial cells is safe and well tolerated in patients with refractory complex perianal Crohn's disease: a phase I open label study with long-term follow up"],"prefix":"10.1016","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7040-3441","authenticated-orcid":false,"given":"Charlotte","family":"Keung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thang Chien","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Gerstenmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Sievert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3689-8858","authenticated-orcid":false,"given":"Gregory T.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ebiom.2023.104879_bib1","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1053\/gast.2002.32362","article-title":"The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota","volume":"122","author":"Schwartz","year":"2002","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104879_bib2","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.crohns.2014.03.005","article-title":"IBD and health-related quality of life -- discovering the true impact","volume":"8","author":"Lonnfors","year":"2014","journal-title":"J\u00a0Crohns Colitis"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104879_bib3","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/codi.13311","article-title":"Treatment of perianal fistula in Crohn's disease: a systematic review and meta-analysis comparing seton drainage and anti-tumour necrosis factor treatment","volume":"18","author":"de Groof","year":"2016","journal-title":"Colorectal Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104879_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ecco-jcc\/jjz180","article-title":"ECCO guidelines on therapeutics in crohn's disease: medical treatment","volume":"14","author":"Torres","year":"2020","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.ebiom.2023.104879_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/ecco-jcc\/jjaa118","article-title":"The incidence and disease course of perianal crohn's disease: a Danish Nationwide Cohort Study, 1997-2015","volume":"15","author":"Wewer","year":"2020","journal-title":"J\u00a0Crohns Colitis"},{"issue":"10051","key":"10.1016\/j.ebiom.2023.104879_bib6","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","article-title":"Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial","volume":"388","author":"Panes","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104879_bib7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13287-017-0570-x","article-title":"Systematic review with meta-analysis: the efficacy and safety of stem cell therapy for Crohn's disease","volume":"8","author":"Qiu","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.ebiom.2023.104879_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/j.gastro.2017.12.020","article-title":"Long-term efficacy and safety of stem cell therapy (Cx601) for complex perianal fistulas in patients with Crohn's disease","volume":"154","author":"Pan\u00e9s","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ebiom.2023.104879_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8816737","article-title":"Efficacy and safety of mesenchymal stem cells in treatment of complex perianal fistulas: a meta-analysis","volume":"2020","author":"Cheng","year":"2020","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.ebiom.2023.104879_bib10","series-title":"Darvadstrocel for treating complex perianal fistulas in Crohn's disease","author":"NICE","year":"2019"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104879_bib11","first-page":"114","article-title":"Impact of donor characteristics on the quality of bone marrow as a source of mesenchymal stromal cells","volume":"7","author":"Barreto-Duran","year":"2018","journal-title":"Am J Stem Cells"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104879_bib12","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00003226-200005000-00018","article-title":"Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane","volume":"19","author":"Hao","year":"2000","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104879_bib13","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1167\/iovs.04-0495","article-title":"Immunosuppressive factors secreted by human amniotic epithelial cells","volume":"46","author":"Li","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104879_bib14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/(SICI)1097-4652(199906)179:3<325::AID-JCP10>3.0.CO;2-X","article-title":"Suppression of transforming growth factor-beta isoforms, TGF-beta receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix","volume":"179","author":"Tseng","year":"1999","journal-title":"J\u00a0Cell Physiol"},{"issue":"Supplement 1","key":"10.1016\/j.ebiom.2023.104879_bib15","first-page":"S072","article-title":"Human amnion epithelial cells and their conditioned media reduces intestinal inflammation and fibrosis in a murine model of chronic colitis","volume":"12","author":"Kuk JC","year":"2018","journal-title":"J\u00a0Crohns Colitis"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104879_bib16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s100380050205","article-title":"Human amniotic epithelial cells are promising transgene carriers for allogeneic cell transplantation into liver","volume":"45","author":"Sakuragawa","year":"2000","journal-title":"J\u00a0Hum Genet"},{"issue":"8254","key":"10.1016\/j.ebiom.2023.104879_bib17","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0140-6736(81)91212-5","article-title":"Immunogenicity of human amniotic epithelial cells after transplantation into volunteers","volume":"2","author":"Akle","year":"1981","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104879_bib18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/sctm.19-0251","article-title":"Two-year outcomes of infants enrolled in the first-in-human study of amnion cells for bronchopulmonary dysplasia","volume":"9","author":"Malhotra","year":"2020","journal-title":"Stem Cells Transl Med"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104879_bib19","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ajmg.1320220219","article-title":"A\u00a0therapeutic trial of amniotic epithelial cell implantation in patients with lysosomal storage diseases","volume":"22","author":"Yeager","year":"1985","journal-title":"Am J Med Genet"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104879_bib20","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/sctm.18-0079","article-title":"First-in-human administration of allogeneic amnion cells in premature infants with bronchopulmonary dysplasia: a safety study","volume":"7","author":"Lim","year":"2018","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.ebiom.2023.104879_bib21","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3389\/fphar.2017.00549","article-title":"A\u00a0pilot study evaluating the safety of intravenously administered human amnion epithelial cells for the treatment of hepatic fibrosis","volume":"8","author":"Lim","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ebiom.2023.104879_bib22","article-title":"Phase I trial outcome of amnion cell therapy in patients with ischemic stroke (I-ACT)","volume":"17","author":"Phan","year":"2023","journal-title":"Front Neurosci"},{"issue":"Supplement 1","key":"10.1016\/j.ebiom.2023.104879_bib23","first-page":"S072","article-title":"Human amnion epithelial cells reduce intestinal inflammation in a 2,4,6-trinitrobenzene sulfonic acid induced model of acute colitis","volume":"12","author":"Kuk JC","year":"2018","journal-title":"J\u00a0Crohns Colitis"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104879_bib24","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.gastro.2003.08.025","article-title":"AGA technical review on perianal Crohn's disease","volume":"125","author":"Sandborn","year":"2003","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104879_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00004836-199501000-00008","article-title":"Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group","volume":"20","author":"Irvine","year":"1995","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104879_bib26","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/ibd.20826","article-title":"Assessing the activity of perianal Crohn's disease: comparison of clinical indices and computer-assisted anal ultrasound","volume":"15","author":"Losco","year":"2009","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104879_bib27","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/apt.14190","article-title":"The development of a magnetic resonance imaging index for fistulising Crohn's disease","volume":"46","author":"Samaan","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104879_bib28","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1053\/j.gastro.2019.07.027","article-title":"Development and validation of a magnetic resonance index for assessing fistulas in patients with crohn's disease","volume":"157","author":"Hindryckx","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ebiom.2023.104879_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/9780470151808.sc01e06s13","article-title":"Amnion epithelial cell isolation and characterization for clinical use","author":"Murphy","year":"2010","journal-title":"Curr Protoc Stem Cell Biol"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104879_bib30","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s11605-018-3895-6","article-title":"A\u00a0step-by-step surgical protocol for the treatment of perianal fistula with adipose-derived mesenchymal stem cells","volume":"22","author":"Georgiev-Hristov","year":"2018","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.ebiom.2023.104879_bib31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.intimp.2016.01.019","article-title":"The effect of local anesthetic on pro-inflammatory macrophage modulation by mesenchymal stromal cells","volume":"33","author":"Gray","year":"2016","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104879_bib32","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1002\/stem.1357","article-title":"Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for Crohn's fistula","volume":"31","author":"Lee","year":"2013","journal-title":"Stem Cell"},{"key":"10.1016\/j.ebiom.2023.104879_bib33","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6132340","article-title":"Stem cell therapy: a compassionate use program in perianal fistula","volume":"2019","author":"Herreros","year":"2019","journal-title":"Stem Cells Int"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104879_bib34","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13287-020-01636-4","article-title":"Autologous adipose-derived stem cells for the treatment of Crohn's fistula-in-ano: an open-label, controlled trial","volume":"11","author":"Zhou","year":"2020","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104879_bib35","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00384-012-1581-9","article-title":"Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I\/IIa clinical trial","volume":"28","author":"de la Portilla","year":"2013","journal-title":"Int J Colorectal Dis"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104879_bib36","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.5966\/sctm.2015-0356","article-title":"Treatment of crohn's-related rectovaginal fistula with allogeneic expanded-adipose derived stem cells: a phase I-IIa clinical trial","volume":"5","author":"Garcia-Arranz","year":"2016","journal-title":"Stem Cells Transl Med"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104879_bib37","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/codi.13223","article-title":"Allogeneic adipose-derived stem cells for the treatment of perianal fistula in Crohn's disease: a pilot clinical trial","volume":"18","author":"Park","year":"2016","journal-title":"Colorectal Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104879_bib38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/DCR.0b013e3181973487","article-title":"Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial","volume":"52","author":"Garcia-Olmo","year":"2009","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104879_bib39","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/gut.2010.214841","article-title":"Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease","volume":"60","author":"Ciccocioppo","year":"2011","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104879_bib40","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3727\/096368912X656045","article-title":"Autologous adipose tissue-derived stem cells for the treatment of Crohn's fistula: a phase I clinical study","volume":"22","author":"Cho","year":"2013","journal-title":"Cell Transplant"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104879_bib41","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1007\/s10350-005-0052-6","article-title":"A\u00a0phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation","volume":"48","author":"Garcia-Olmo","year":"2005","journal-title":"Dis Colon Rectum"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104879_bib42","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.3748\/wjg.v21.i11.3330","article-title":"Recurrent anal fistulae: limited surgery supported by stem cells","volume":"21","author":"Garcia-Olmo","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ebiom.2023.104879_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110265","article-title":"Cytokine-stimulated human amniotic epithelial cells alleviate DSS-induced colitis in mice through anti-inflammation and regulating Th17\/Treg balance","volume":"120","author":"Wang","year":"2023","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104879_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/cells8070764","article-title":"Mesenchymal stem cells for perianal crohn's disease","volume":"8","author":"Carvello","year":"2019","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104879_bib45","doi-asserted-by":"crossref","first-page":"241","DOI":"10.15283\/ijsc21032","article-title":"Therapeutic aspects of mesenchymal stem cell-based cell therapy with a focus on human amniotic epithelial cells in multiple sclerosis: a mechanistic review","volume":"14","author":"ArefNezhad","year":"2021","journal-title":"Int J Stem Cells"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104879_bib46","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1186\/s13104-017-2880-6","article-title":"Method and key points for isolation of human amniotic epithelial cells with high yield, viability and purity","volume":"10","author":"Motedayyen","year":"2017","journal-title":"BMC Res Notes"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104879_bib47","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1177\/0963689719837897","article-title":"The pros and cons of mesenchymal stem cell-based therapies","volume":"28","author":"Musial-Wysocka","year":"2019","journal-title":"Cell Transplant"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104879_bib48","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1053\/j.gastro.2015.06.014","article-title":"Allogeneic bone marrow-derived mesenchymal stromal cells promote healing of refractory perianal fistulas in patients with crohn's disease","volume":"149","author":"Molendijk","year":"2015","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104879_bib49","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/ecco-jcc\/jjy220","article-title":"Lymphoproliferative disease in the rectum 4 Years after local mesenchymal stromal cell therapy for refractory perianal crohn's fistulas: a case report","volume":"13","author":"Barnhoorn","year":"2019","journal-title":"J\u00a0Crohns Colitis"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104879_bib50","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1634\/stemcells.2004-0357","article-title":"Stem cell characteristics of amniotic epithelial cells","volume":"23","author":"Miki","year":"2005","journal-title":"Stem Cell"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423004450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423004450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T14:42:26Z","timestamp":1737384146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396423004450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":50,"alternative-id":["S2352396423004450"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104879","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Local fistula injection of allogeneic human amnion epithelial cells is safe and well tolerated in patients with refractory complex perianal Crohn's disease: a phase I open label study with long-term follow up","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104879","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104879"}}